Display options
Cite
van Andel L, Rosing H, Zhang Z, et al. Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a . Cancer Chemother Pharmacol. 2018;81(1):47doi: 10.1007/s00280-017-3474-7.
van Andel, L., Rosing, H., Zhang, Z., Hughes, L., Kansra, V., Sanghvi, M., Tibben, M. M., Gebretensae, A., Schellens, J. H. M., & Beijnen, J. H. (2018). Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a . Cancer chemotherapy and pharmacology, 81(1), 47. https://doi.org/10.1007/s00280-017-3474-7
van Andel, L, et al. "Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a ." Cancer chemotherapy and pharmacology vol. 81,1 (2018): 47. doi: https://doi.org/10.1007/s00280-017-3474-7
van Andel L, Rosing H, Zhang Z, Hughes L, Kansra V, Sanghvi M, Tibben MM, Gebretensae A, Schellens JHM, Beijnen JH. Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a . Cancer Chemother Pharmacol. 2018 Jan;81(1):47. doi: 10.1007/s00280-017-3474-7. PMID: 29181573; PMCID: PMC5754421.
Copy Download .nbib Format: NLM
Share it on

Cancer Chemother Pharmacol. 2018 Jan;81(1):47. doi: 10.1007/s00280-017-3474-7.

Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a .

Cancer chemotherapy and pharmacology

L van Andel, H Rosing, Z Zhang, L Hughes, V Kansra, M Sanghvi, M M Tibben, A Gebretensae, J H M Schellens, J H Beijnen

Affiliations

  1. Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands. [email protected].
  2. Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute and MC Slotervaart, PO Box 90440, 1006 BK, Amsterdam, The Netherlands.
  3. TESARO, Inc., Waltham, MA, USA.
  4. Xceleron, Inc., A Pharmaron Company, Germantown, MD, USA.
  5. Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  6. Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.

PMID: 29181573 PMCID: PMC5754421 DOI: 10.1007/s00280-017-3474-7

Abstract

The article ''Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a

Publication Types